[Drug evaluation and supreme responsibility of medical practitioners].
Zeng
Qing-yu
QY
qyzeng@stu.edu.cn
D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects; D004341:Drug Evaluation; D006801:Humans; D007783:Lactones / Q000009:adverse effects; D017410:Practice Guidelines as Topic; D013450:Sulfones / Q000009:adverse effects
D052246:Cyclooxygenase 2 Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib